Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.530
-0.170 (-3.62%)
At close: Mar 6, 2026, 4:00 PM EST
4.510
-0.020 (-0.44%)
After-hours: Mar 6, 2026, 6:30 PM EST

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of $871.23 million as of March 6, 2026. Its market cap has increased by 35.62% in one year.

Market Cap
871.23M
Enterprise Value
782.13M
1-Year Change
35.62%
Ranking
Category
Stock Price
$4.53

Market Cap Chart

Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $871.23M, an increase of 1,734.16%. That is a compound annual growth rate of 19.69%.

History

DateMarket Cap% Change
Mar 5, 2026903.90M-2.29%
Dec 31, 2025925.10M49.31%
Dec 31, 2024619.60M47.81%
Dec 29, 2023419.20M14.98%
Dec 30, 2022364.60M-30.71%
Dec 31, 2021526.20M74.59%
Dec 31, 2020301.40M90.76%
Dec 31, 2019158.00M-25.65%
Dec 31, 2018212.50M-23.56%
Dec 29, 2017278.00M106.85%
Dec 30, 2016134.40M-44.65%
Dec 31, 2015242.80M-28.19%
Dec 31, 2014338.10M196.58%
Dec 31, 2013114.00M89.05%
Dec 31, 201260.30M289.03%
Dec 30, 201115.50M-68.04%
Dec 31, 201048.50M2.11%
Dec 31, 200947.50M-
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Maravai LifeSciences Holdings 912.59M
Fortrea Holdings 898.54M
ARS Pharmaceuticals 895.57M
SpyGlass Pharma 888.91M
uniQure 888.90M
Arvinas 869.87M
Janux Therapeutics 841.91M
Phathom Pharmaceuticals 840.78M
Market Cap Rankings